Stryker Free Cash Flow 2010-2024 | SYK
Stryker annual/quarterly free cash flow history and growth rate from 2010 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
- Stryker free cash flow for the quarter ending September 30, 2024 was 1,822.00, a year-over-year.
- Stryker free cash flow for the twelve months ending September 30, 2024 was , a year-over-year.
- Stryker annual free cash flow for 2023 was $3.136B, a 54.03% increase from 2022.
- Stryker annual free cash flow for 2022 was $2.036B, a 25.64% decline from 2021.
- Stryker annual free cash flow for 2021 was $2.738B, a 1.86% decline from 2020.
| Stryker Annual Free Cash Flow | |
|---|---|
| 2023 | 3,136.00 |
| 2022 | 2,036.00 |
| 2021 | 2,738.00 |
| 2020 | 2,790.00 |
| 2019 | 1,542.00 |
| 2018 | 2,038.00 |
| 2017 | 961.00 |
| 2016 | 1,425.00 |
| 2015 | 711.00 |
| 2014 | 1,549.00 |
| 2013 | 1,691.00 |
| 2012 | 1,447.00 |
| 2011 | 1,275.00 |
| 2010 | 1,426.00 |
| 2009 | 1,331.00 |
| Stryker Quarterly Free Cash Flow | |
|---|---|
| 2024-09-30 | 1,822.00 |
| 2024-06-30 | 518.00 |
| 2024-03-31 | 37.00 |
| 2023-12-31 | 3,136.00 |
| 2023-09-30 | 1,753.00 |
| 2023-06-30 | 851.00 |
| 2023-03-31 | 315.00 |
| 2022-12-31 | 2,036.00 |
| 2022-09-30 | 1,221.00 |
| 2022-06-30 | 470.00 |
| 2022-03-31 | 84.00 |
| 2021-12-31 | 2,738.00 |
| 2021-09-30 | 1,944.00 |
| 2021-06-30 | 1,141.00 |
| 2021-03-31 | 369.00 |
| 2020-12-31 | 2,790.00 |
| 2020-09-30 | 1,718.00 |
| 2020-06-30 | 958.00 |
| 2020-03-31 | 447.00 |
| 2019-12-31 | 1,542.00 |
| 2019-09-30 | 1,006.00 |
| 2019-06-30 | 540.00 |
| 2019-03-31 | 191.00 |
| 2018-12-31 | 2,038.00 |
| 2018-09-30 | 1,146.00 |
| 2018-06-30 | 668.00 |
| 2018-03-31 | 176.00 |
| 2017-12-31 | 961.00 |
| 2017-09-30 | 468.00 |
| 2017-06-30 | 531.00 |
| 2017-03-31 | 12.00 |
| 2016-12-31 | 1,425.00 |
| 2016-09-30 | 1,679.00 |
| 2016-06-30 | 526.00 |
| 2016-03-31 | 147.00 |
| 2015-12-31 | 711.00 |
| 2015-09-30 | 37.00 |
| 2015-06-30 | 623.00 |
| 2015-03-31 | 334.00 |
| 2014-12-31 | 1,549.00 |
| 2014-09-30 | 931.00 |
| 2014-06-30 | 455.00 |
| 2014-03-31 | 139.00 |
| 2013-12-31 | 1,691.00 |
| 2013-09-30 | 1,075.00 |
| 2013-06-30 | 496.00 |
| 2013-03-31 | 187.00 |
| 2012-12-31 | 1,447.00 |
| 2012-09-30 | 900.00 |
| 2012-06-30 | 389.00 |
| 2012-03-31 | -17.00 |
| 2011-12-31 | 1,275.00 |
| 2011-09-30 | 712.00 |
| 2011-06-30 | 322.00 |
| 2011-03-31 | 209.00 |
| 2010-12-31 | 1,426.00 |
| 2010-09-30 | 957.00 |
| 2010-06-30 | 533.20 |
| 2010-03-31 | 243.70 |
| 2009-12-31 | 1,331.00 |
| 2009-09-30 | 832.50 |
| 2009-06-30 | 152.20 |
| 2009-03-31 | 242.50 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $139.395B | $20.498B |
| Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $194.797B | 24.85 |
| Boston Scientific (BSX) | United States | $139.837B | 40.20 |
| EssilorLuxottica (ESLOY) | France | $110.104B | 0.00 |
| Medtronic (MDT) | Ireland | $103.429B | 15.36 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.664B | 0.00 |
| Haleon (HLN) | United Kingdom | $41.193B | 26.76 |
| GE HealthCare Technologies (GEHC) | United States | $38.725B | 20.09 |
| ResMed (RMD) | United States | $34.324B | 28.21 |
| Terumo (TRUMY) | Japan | $28.025B | 39.58 |
| Koninklijke Philips (PHG) | Netherlands | $24.269B | 18.58 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.811B | 13.25 |
| Insulet (PODD) | United States | $19.068B | 75.93 |
| Baxter (BAX) | United States | $15.022B | 9.77 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.471B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.568B | 32.52 |
| BellRing Brands (BRBR) | United States | $9.145B | 36.79 |
| Demant (WILYY) | Denmark | $8.596B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.666B | 15.49 |
| Haemonetics (HAE) | United States | $3.851B | 18.79 |
| ICU Medical (ICUI) | United States | $3.779B | 35.98 |
| Prestige Consumer Healthcare (PBH) | United States | $3.656B | 18.18 |
| Perrigo (PRGO) | Ireland | $3.326B | 9.79 |
| Envista Holdings (NVST) | United States | $3.198B | 23.82 |
| QuidelOrtho (QDEL) | United States | $3.077B | 19.81 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| Neogen (NEOG) | United States | $2.678B | 30.90 |
| GN Store Nord (GNNDY) | Denmark | $2.593B | 16.63 |
| LeMaitre Vascular (LMAT) | United States | $2.104B | 51.14 |
| Green Thumb Industries (GTBIF) | United States | $1.564B | 27.37 |
| AtriCure (ATRC) | United States | $1.531B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.364B | 9.75 |
| InMode (INMD) | Israel | $1.335B | 8.03 |
| BioLife Solutions (BLFS) | United States | $1.234B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.225B | 0.00 |
| Owens & Minor (OMI) | United States | $1.071B | 8.37 |
| Curaleaf Holdings (CURLF) | Canada | $0.942B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.812B | 14.32 |
| CeriBell (CBLL) | United States | $0.750B | 0.00 |
| Evolus (EOLS) | United States | $0.633B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.600B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.551B | 24.31 |
| Surmodics (SRDX) | United States | $0.549B | 0.00 |
| Omeros (OMER) | United States | $0.512B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.459B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.423B | 0.00 |
| ZimVie (ZIMV) | United States | $0.372B | 31.37 |
| Valneva SE (VALN) | France | $0.369B | 0.00 |
| Quanterix (QTRX) | United States | $0.363B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.310B | 29.44 |
| Biote (BTMD) | United States | $0.307B | 6.73 |
| Cerus (CERS) | United States | $0.293B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.282B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.270B | 18.10 |
| Canopy Growth (CGC) | Canada | $0.267B | 0.00 |
| High Tide (HITI) | Canada | $0.250B | 103.00 |
| Zynex (ZYXI) | United States | $0.249B | 52.20 |
| Aurora Cannabis (ACB) | Canada | $0.227B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.224B | 3.15 |
| Utah Medical Products (UTMD) | United States | $0.207B | 14.26 |
| MacroGenics (MGNX) | United States | $0.200B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.198B | 0.00 |
| Brainsway (BWAY) | Israel | $0.177B | 94.00 |
| TerrAscend (TSNDF) | Canada | $0.164B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.157B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 17.21 |
| Quipt Home Medical (QIPT) | United States | $0.129B | 0.00 |
| Jin Medical (ZJYL) | China | $0.126B | 0.00 |
| Veru (VERU) | United States | $0.114B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 10.88 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
| InterCure (INCR) | Israel | $0.076B | 0.00 |
| INLIF (INLF) | $0.068B | 0.00 | |
| Rockwell Medical (RMTI) | United States | $0.067B | 34.67 |
| Apyx Medical (APYX) | United States | $0.060B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| Exagen (XGN) | United States | $0.056B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.052B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.051B | 0.00 |
| ImmuCell (ICCC) | United States | $0.046B | 0.00 |
| Modular Medical (MODD) | United States | $0.046B | 0.00 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 13.30 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |